glp 1 aafp Determining When to Recommend Glucose-Lowering Drugs That Reduce Cardiovascular Risk GLP-1a: Going beyond Traditional Use

Read on!

Understanding how GLP-1 injections affect your palate helps you prepare for treatment and manage expectations

Patients switch because of efficacy, tolerability, access, cost, insurance coverage, or newer options becoming available

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential treatments for substance use disorders

GLP-1 receptor agonists like semaglutide were developed for glucose regulation and weight management, not fibromyalgia treatment

Results Overall, 16 injectable semaglutide, 8 oral semaglutide, and 2 injectable liraglutide follow-on products were analyzed alongside originator products